312 related articles for article (PubMed ID: 35035786)
1. Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning.
Yang J; Ju J; Guo L; Ji B; Shi S; Yang Z; Gao S; Yuan X; Tian G; Liang Y; Yuan P
Comput Struct Biotechnol J; 2022; 20():333-342. PubMed ID: 35035786
[TBL] [Abstract][Full Text] [Related]
2. Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer.
Farahmand S; Fernandez AI; Ahmed FS; Rimm DL; Chuang JH; Reisenbichler E; Zarringhalam K
Mod Pathol; 2022 Jan; 35(1):44-51. PubMed ID: 34493825
[TBL] [Abstract][Full Text] [Related]
3. ICSDA: a multi-modal deep learning model to predict breast cancer recurrence and metastasis risk by integrating pathological, clinical and gene expression data.
Yao Y; Lv Y; Tong L; Liang Y; Xi S; Ji B; Zhang G; Li L; Tian G; Tang M; Hu X; Li S; Yang J
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36242564
[TBL] [Abstract][Full Text] [Related]
4. Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR
Hu J; Lv H; Zhao S; Lin CJ; Su GH; Shao ZM
J Thorac Dis; 2023 May; 15(5):2528-2543. PubMed ID: 37324098
[TBL] [Abstract][Full Text] [Related]
5. Predicting the prognosis of HER2-positive breast cancer patients by fusing pathological whole slide images and clinical features using multiple instance learning.
Wang Y; Zhang L; Li Y; Wu F; Cao S; Ye F
Math Biosci Eng; 2023 Apr; 20(6):11196-11211. PubMed ID: 37322978
[TBL] [Abstract][Full Text] [Related]
6. Predicting breast cancer recurrence and metastasis risk by integrating color and texture features of histopathological images and machine learning technologies.
Liu X; Yuan P; Li R; Zhang D; An J; Ju J; Liu C; Ren F; Hou R; Li Y; Yang J
Comput Biol Med; 2022 Jul; 146():105569. PubMed ID: 35751195
[TBL] [Abstract][Full Text] [Related]
7. Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers.
Huang Y; Yao Z; Li L; Mao R; Huang W; Hu Z; Hu Y; Wang Y; Guo R; Tang X; Yang L; Wang Y; Luo R; Yu J; Zhou J
EBioMedicine; 2023 Aug; 94():104706. PubMed ID: 37478528
[TBL] [Abstract][Full Text] [Related]
8. DeepLRHE: A Deep Convolutional Neural Network Framework to Evaluate the Risk of Lung Cancer Recurrence and Metastasis From Histopathology Images.
Wu Z; Wang L; Li C; Cai Y; Liang Y; Mo X; Lu Q; Dong L; Liu Y
Front Genet; 2020; 11():768. PubMed ID: 33193560
[TBL] [Abstract][Full Text] [Related]
9. Deep Learning to Estimate Human Epidermal Growth Factor Receptor 2 Status from Hematoxylin and Eosin-Stained Breast Tissue Images.
Anand D; Kurian NC; Dhage S; Kumar N; Rane S; Gann PH; Sethi A
J Pathol Inform; 2020; 11():19. PubMed ID: 33033656
[TBL] [Abstract][Full Text] [Related]
10. A Deep Learning Quantification Algorithm for HER2 Scoring of Gastric Cancer.
Han Z; Lan J; Wang T; Hu Z; Huang Y; Deng Y; Zhang H; Wang J; Chen M; Jiang H; Lee RG; Gao Q; Du M; Tong T; Chen G
Front Neurosci; 2022; 16():877229. PubMed ID: 35706692
[TBL] [Abstract][Full Text] [Related]
11. Deep learning-based predictive model for pathological complete response to neoadjuvant chemotherapy in breast cancer from biopsy pathological images: a multicenter study.
Zeng H; Qiu S; Zhuang S; Wei X; Wu J; Zhang R; Chen K; Wu Z; Zhuang Z
Front Physiol; 2024; 15():1279982. PubMed ID: 38357498
[No Abstract] [Full Text] [Related]
12. Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy.
Bychkov D; Linder N; Tiulpin A; Kücükel H; Lundin M; Nordling S; Sihto H; Isola J; Lehtimäki T; Kellokumpu-Lehtinen PL; von Smitten K; Joensuu H; Lundin J
Sci Rep; 2021 Feb; 11(1):4037. PubMed ID: 33597560
[TBL] [Abstract][Full Text] [Related]
13. Use of Deep Learning to Develop and Analyze Computational Hematoxylin and Eosin Staining of Prostate Core Biopsy Images for Tumor Diagnosis.
Rana A; Lowe A; Lithgow M; Horback K; Janovitz T; Da Silva A; Tsai H; Shanmugam V; Bayat A; Shah P
JAMA Netw Open; 2020 May; 3(5):e205111. PubMed ID: 32432709
[TBL] [Abstract][Full Text] [Related]
14. Lung Cancer Diagnosis on Virtual Histologically Stained Tissue Using Weakly Supervised Learning.
Chen Z; Wong IHM; Dai W; Lo CTK; Wong TTW
Mod Pathol; 2024 Apr; 37(6):100487. PubMed ID: 38588884
[TBL] [Abstract][Full Text] [Related]
15. Outcome-Supervised Deep Learning on Pathologic Whole Slide Images for Survival Prediction of Immunotherapy in Patients with Non-Small Cell Lung Cancer.
Li B; Yang L; Zhang H; Li H; Jiang C; Yao Y; Cheng S; Zou B; Fan B; Dong T; Wang L
Mod Pathol; 2023 Aug; 36(8):100208. PubMed ID: 37149222
[TBL] [Abstract][Full Text] [Related]
16. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
[TBL] [Abstract][Full Text] [Related]
17. Automated segmentation of cell membranes to evaluate HER2 status in whole slide images using a modified deep learning network.
Khameneh FD; Razavi S; Kamasak M
Comput Biol Med; 2019 Jul; 110():164-174. PubMed ID: 31163391
[TBL] [Abstract][Full Text] [Related]
18. Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study.
Yamashita R; Long J; Longacre T; Peng L; Berry G; Martin B; Higgins J; Rubin DL; Shen J
Lancet Oncol; 2021 Jan; 22(1):132-141. PubMed ID: 33387492
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Target-Drug Therapy by Identifying Gene Mutations in Lung Cancer With Histopathological Stained Image and Deep Learning Techniques.
Huang K; Mo Z; Zhu W; Liao B; Yang Y; Wu FX
Front Oncol; 2021; 11():642945. PubMed ID: 33928031
[TBL] [Abstract][Full Text] [Related]
20. HAHNet: a convolutional neural network for HER2 status classification of breast cancer.
Wang J; Zhu X; Chen K; Hao L; Liu Y
BMC Bioinformatics; 2023 Sep; 24(1):353. PubMed ID: 37730567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
